SHARE THIS VIDEO —
FDA approves first medical treatment for Alzheimer’s in 18 years
This version of Mmvo114445381880 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.
NBC News Clone will keep curating essential reads for you — simplified and optimized.
